Autoimmune Type 1 Diabetes Franchise Head Italy

Start free →

Or apply yourself on the official page →

About the role

Head of Autoimmune Diabetes T1D Italy • Location: Milan • Job type: Permanent, Full-time About the role As Head of Autoimmune Diabetes T1D Italy , you will lead the launch in Italy of this breakthrough therapy. You'll drive commercial strategy, build health system readiness, and help redefine the standard of care in preventive medicine — all while working in one of pharma's most dynamic and high-visibility spaces. You will report directly to the General Manager and also be a member of the GenMed Italy leadership team, having a meaningful impact above your T1D franchise Head role and supporting the vision and ambition of the entire GBU in Italy. Ready to get started ? About Sanofi: At Sanofi, we chase the miracles of science to improve people's lives. Tzield/Teizeild — our first-in-class, disease-modifying therapy for Autoimmune Type 1 Diabetes — is re-defining the way we used to manage T1D. Approved in the US, EU, UK, China, Canada, Australia and beyond, it delays the onset of stage 3 T1D and gives patients and families more time and hope. Our target is to launch it in Italy by mid-2027.    Key Responsibilities : • Lead the T1D team to launch successfully Tzield/Teizeild in the Italy • co-build the Integrated Growth Plan with Global, translate insights into local execution, and track performance through meaningful KPIs • Collaborate cross-functionally (e.g., Medical, Market Access, Public Affairs, Communications) — define a broad stakeholder engagement strategy by understanding how stakeholders impact each other in ecosystem (e.g., COEs, KOLs, HCPs, DOLs, scientific societies, PAGs, policy makers, payers, think-tanks, etc.) and tailor engagement to their level of maturity in T1D journey • Adapt and execute Glocal state of the art — multi-factorial stakeholder engagement to local context (incl. Omnichannel with compelling narrative/content) • Secure optimal market access for Teizeild — obtain the best access that reflects its therapeutic innovation • Drive treatment launch uptake — support infusion readiness in the centers of excellence, develop acceptance of Teizeild, conviction in the health care community, to establish it as the reference therapy in pre-clinical T1D • undefined • Shape the healthcare system to ensure full readiness at time of launch and beyond: • Accelerate screening — scale the detection of at-risk patients at the right moment in their T1D journey, building on established foundations • & Accompany the long-term screening access strategy in Italy — coordinate action across Population Health, Medical, Public Affairs and Communications to secure sustainable access to screening • Drive innovation to accelerate and simplify the pre-clinical T1D patient journey — leverage AI models to identify at-risk patients and predict disease progression, enabling earlier and more precise intervention • Expand the ecosystem — strengthen partnerships across screening players, COEs, payers and patient communities to ensure a seamless pathway from screening to treatment • Anticipate the future of immunotherapy in T1D — beyond Teizeild, help shape the landscape for Sanofi's upcoming pipeline innovations and establish Sanofi's scientific leadership in T1D • Monitor and stay ahead of market trends and developments — drive improvements in business outcomes and customer experience • Lead and grow the team — continue developing a best-in-class commercial organization (marketing, sales, patient experience, pathway management) with an intrapreneurial mindset • Contribute in the GenMed Italy Leadership team as core member to define the vision, roadmap and ambition of GenMed Italy including performance, transformation and talent development.   About you : Experience: Desired experience in Specialty / Rare disease / Type 1

View the official posting →